Following Romanian Competition Council’s approval, Ranbaxy Laboratories Ltd. has completed its acquisition of a 96.7% stake by Ranbaxy Netherlands BV in the leading Romanian pharmaceutical company Terapia S.A.
As previously announced by Ranbaxy, the acquisition of the equity stake in Terapia from Terapia Holding BV was a sum of US $ 324 Mn --a deal strengthening the capacity of these two premier generic companies, not to mention allowing Ranbaxy to expand in the rapidly growing Romanian pharmaceutical market.
Read more at Ranbaxy press release or the Terapia S.A. press release.
Comment Preview